New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Benefits of garlic extend to Alzheimer's

Benefits of garlic extend to Alzheimer's

by Dr Laura Glitsos,ParticleCredit: CC0 Public DomainWhile garlic breath might not be good for your social life, Curtin University researchers have found a certain garlic extract that may fight
Neurology May 20,2024
Benefits of garlic extend to Alzheimer's

Benefits of garlic extend to Alzheimer's

by Dr Laura Glitsos,ParticleCredit: CC0 Public DomainWhile garlic breath might not be good for your social life, Curtin University researchers have found a certain garlic extract that may fight
Neurology May 20,2024
When someone living with dementia is distressed or violent, 'de-escalation' is vital

When someone living with dementia is distressed or violent, 'de-escalation' is vital

by Steve Macfarlane,The ConversationCredit: AI-generated imageToday'sreportingabout the alleged tasering of a 95-year-old woman living at the Yallambee Lodge aged care home in Ne
Neurology May 20,2024
When someone living with dementia is distressed or violent, 'de-escalation' is vital

When someone living with dementia is distressed or violent, 'de-escalation' is vital

by Steve Macfarlane,The ConversationCredit: AI-generated imageToday'sreportingabout the alleged tasering of a 95-year-old woman living at the Yallambee Lodge aged care home in Ne
Neurology May 20,2024
Over 1.2 million people in England and Wales will be living with dementia by 2040

Over 1.2 million people in England and Wales will be living with dementia by 2040

by British Medical JournalCredit: CC0 Public DomainBy 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), largely due to increase
Neurology May 20,2024
Over 1.2 million people in England and Wales will be living with dementia by 2040

Over 1.2 million people in England and Wales will be living with dementia by 2040

by British Medical JournalCredit: CC0 Public DomainBy 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), largely due to increase
Neurology May 20,2024
A million Aussies will have dementia by 2056, so now is the time to act on prevention

A million Aussies will have dementia by 2056, so now is the time to act on prevention

by Cate Swannell, Medical Journal of AustraliaCredit: CC0 Public DomainDementia prevention needs to be Australia's next public health area of focus, as the nation heads towards a projected number
Neurology May 20,2024
A million Aussies will have dementia by 2056, so now is the time to act on prevention

A million Aussies will have dementia by 2056, so now is the time to act on prevention

by Cate Swannell, Medical Journal of AustraliaCredit: CC0 Public DomainDementia prevention needs to be Australia's next public health area of focus, as the nation heads towards a projected number
Neurology May 20,2024
Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzhe
Neurology May 20,2024
Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzhe
Neurology May 20,2024
Big data initiative discovers new causal pathways in Alzheimer's

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a
Neurology May 20,2024
Big data initiative discovers new causal pathways in Alzheimer's

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a
Neurology May 20,2024
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39
Neurology May 20,2024
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39
Neurology May 20,2024
Single brain scan can diagnose Alzheimer's disease

Single brain scan can diagnose Alzheimer's disease

by Imperial College LondonPET scan of a human brain with Alzheimer's disease. Credit: public domainThe research uses machine learning technology to look at structural features within the brai
Neurology May 20,2024
Single brain scan can diagnose Alzheimer's disease

Single brain scan can diagnose Alzheimer's disease

by Imperial College LondonPET scan of a human brain with Alzheimer's disease. Credit: public domainThe research uses machine learning technology to look at structural features within the brai
Neurology May 20,2024
Single dual time-point PET scan identifies dual Alzheimer's biomarkers

Single dual time-point PET scan identifies dual Alzheimer's biomarkers

by Society of Nuclear MedicineWhile subject #1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in
Neurology May 20,2024
Single dual time-point PET scan identifies dual Alzheimer's biomarkers

Single dual time-point PET scan identifies dual Alzheimer's biomarkers

by Society of Nuclear MedicineWhile subject #1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in
Neurology May 20,2024
Approximately half of AD dementia cases are mild, one-fifth are severe

Approximately half of AD dementia cases are mild, one-fifth are severe

by Boston University School of MedicineCredit: CC0 Public DomainWhat percent of patients with Alzheimer's Disease (AD) currently have severe dementia? Do more people have mild disease? Or are
Neurology May 20,2024
Approximately half of AD dementia cases are mild, one-fifth are severe

Approximately half of AD dementia cases are mild, one-fifth are severe

by Boston University School of MedicineCredit: CC0 Public DomainWhat percent of patients with Alzheimer's Disease (AD) currently have severe dementia? Do more people have mild disease? Or are
Neurology May 20,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com